APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Formulation Development Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Formulation Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174214350321 December 2025192 pages

Choose your research edition.

Industry ResearchPharmaceutical Formulation Development Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Formulation Development Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Formulation Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Formulation Development Service Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Formulation Development Service Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Pharmaceutical Formulation Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical Formulation Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Formulation Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Formulation Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Formulation Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Formulation Development Service include Adragos Pharma, Agno Pharma, Ascendia Pharmaceutical Solutions, Aurigene Pharmaceutical Services, Avivia, CMC Pharmaceuticals, Coriolis Pharma, Crystal Pharmatech and Eoltinplas Pharmaceutical Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical Formulation Development Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Formulation Development Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Formulation Development Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Formulation Development Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Formulation Development Service Segment by Company

Adragos Pharma

Agno Pharma

Ascendia Pharmaceutical Solutions

Aurigene Pharmaceutical Services

Avivia

CMC Pharmaceuticals

Coriolis Pharma

Crystal Pharmatech

Eoltinplas Pharmaceutical Company

Intertek

LGM Pharma

Lonza

Lucideon

Scantox

Suven Pharma

Seda

Sharp Services

Kemwell Pharma

Pharmaceutical Formulation Development Service Segment by Type

Poorly Soluble Drug Development Service

Highly Permeable Drug Development Service

Peptide/Protein Drug Development Service

High-Dose Drug Development Service

Pharmaceutical Formulation Development Service Segment by Application

Innovative Drug R&D Companies

Generic Drug Companies

Improved New Drug Companies

Pharmaceutical Formulation Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Formulation Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Formulation Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Formulation Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Formulation Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Formulation Development Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Formulation Development Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Formulation Development Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Poorly Soluble Drug Development Service Table 3. Key Players of Highly Permeable Drug Development Service Table 4. Key Players of Peptide/Protein Drug Development Service Table 3. Key Players of High-Dose Drug Development Service Table 4. Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Innovative Drug R&D Companies Table 6. Key Players of Generic Drug Companies Table 7. Key Players of Improved New Drug Companies Table 8. Global Pharmaceutical Formulation Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmaceutical Formulation Development Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Formulation Development Service Market Share by Region (2021-2026) Table 11. Global Pharmaceutical Formulation Development Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Formulation Development Service Market Share by Region (2027-2032) Table 13. Pharmaceutical Formulation Development Service Industry Trends Table 14. Pharmaceutical Formulation Development Service Industry Drivers Table 15. Pharmaceutical Formulation Development Service Industry Opportunities and Challenges Table 16. Pharmaceutical Formulation Development Service Industry Restraints Table 17. Global Pharmaceutical Formulation Development Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical Formulation Development Service Revenue Market Share by Company (2021-2026) Table 19. Global Pharmaceutical Formulation Development Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical Formulation Development Service Key Company Head Office and Area Served Table 21. Global Pharmaceutical Formulation Development Service Company, Product Type & Application Table 22. Global Pharmaceutical Formulation Development Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical Formulation Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmaceutical Formulation Development Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Formulation Development Service Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical Formulation Development Service Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical Formulation Development Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical Formulation Development Service Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical Formulation Development Service Revenue Market Share by Application (2027-2032) Table 35. Adragos Pharma Company Information Table 36. Adragos Pharma Business Overview Table 37. Adragos Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Adragos Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 39. Adragos Pharma Recent Development Table 40. Agno Pharma Company Information Table 41. Agno Pharma Business Overview Table 42. Agno Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Agno Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 44. Agno Pharma Recent Development Table 45. Ascendia Pharmaceutical Solutions Company Information Table 46. Ascendia Pharmaceutical Solutions Business Overview Table 47. Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Product Portfolio Table 49. Ascendia Pharmaceutical Solutions Recent Development Table 50. Aurigene Pharmaceutical Services Company Information Table 51. Aurigene Pharmaceutical Services Business Overview Table 52. Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Product Portfolio Table 54. Aurigene Pharmaceutical Services Recent Development Table 55. Avivia Company Information Table 56. Avivia Business Overview Table 57. Avivia Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Avivia Pharmaceutical Formulation Development Service Product Portfolio Table 59. Avivia Recent Development Table 60. CMC Pharmaceuticals Company Information Table 61. CMC Pharmaceuticals Business Overview Table 62. CMC Pharmaceuticals Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. CMC Pharmaceuticals Pharmaceutical Formulation Development Service Product Portfolio Table 64. CMC Pharmaceuticals Recent Development Table 65. Coriolis Pharma Company Information Table 66. Coriolis Pharma Business Overview Table 67. Coriolis Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Coriolis Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 69. Coriolis Pharma Recent Development Table 70. Crystal Pharmatech Company Information Table 71. Crystal Pharmatech Business Overview Table 72. Crystal Pharmatech Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Crystal Pharmatech Pharmaceutical Formulation Development Service Product Portfolio Table 74. Crystal Pharmatech Recent Development Table 75. Eoltinplas Pharmaceutical Company Company Information Table 76. Eoltinplas Pharmaceutical Company Business Overview Table 77. Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Product Portfolio Table 79. Eoltinplas Pharmaceutical Company Recent Development Table 80. Intertek Company Information Table 81. Intertek Business Overview Table 82. Intertek Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Intertek Pharmaceutical Formulation Development Service Product Portfolio Table 84. Intertek Recent Development Table 85. LGM Pharma Company Information Table 86. LGM Pharma Business Overview Table 87. LGM Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. LGM Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 89. LGM Pharma Recent Development Table 90. Lonza Company Information Table 91. Lonza Business Overview Table 92. Lonza Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Lonza Pharmaceutical Formulation Development Service Product Portfolio Table 94. Lonza Recent Development Table 95. Lucideon Company Information Table 96. Lucideon Business Overview Table 97. Lucideon Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Lucideon Pharmaceutical Formulation Development Service Product Portfolio Table 99. Lucideon Recent Development Table 100. Scantox Company Information Table 101. Scantox Business Overview Table 102. Scantox Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Scantox Pharmaceutical Formulation Development Service Product Portfolio Table 104. Scantox Recent Development Table 105. Suven Pharma Company Information Table 106. Suven Pharma Business Overview Table 107. Suven Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Suven Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 109. Suven Pharma Recent Development Table 110. Seda Company Information Table 111. Seda Business Overview Table 112. Seda Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Seda Pharmaceutical Formulation Development Service Product Portfolio Table 114. Seda Recent Development Table 115. Sharp Services Company Information Table 116. Sharp Services Business Overview Table 117. Sharp Services Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Sharp Services Pharmaceutical Formulation Development Service Product Portfolio Table 119. Sharp Services Recent Development Table 120. Kemwell Pharma Company Information Table 121. Kemwell Pharma Business Overview Table 122. Kemwell Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Kemwell Pharma Pharmaceutical Formulation Development Service Product Portfolio Table 124. Kemwell Pharma Recent Development Table 125. North America Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Pharmaceutical Formulation Development Service Market Size by Country (2021-2026) Table 131. North America Pharmaceutical Formulation Development Service Market Size by Country (2027-2032) Table 132. Europe Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Pharmaceutical Formulation Development Service Market Size by Country (2021-2026) Table 138. Europe Pharmaceutical Formulation Development Service Market Size by Country (2027-2032) Table 139. China Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 140. China Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 141. China Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 142. China Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Pharmaceutical Formulation Development Service Market Size by Country (2021-2026) Table 149. Asia Pharmaceutical Formulation Development Service Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Pharmaceutical Formulation Development Service Product Image Figure 2. Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical Formulation Development Service Market Share by Type: 2025 VS 2032 Figure 4. Poorly Soluble Drug Development Service Image Figure 5. Highly Permeable Drug Development Service Image Figure 6. Peptide/Protein Drug Development Service Image Figure 7. High-Dose Drug Development Service Image Figure 8. Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmaceutical Formulation Development Service Market Share by Application: 2025 VS 2032 Figure 10. Innovative Drug R&D Companies Image Figure 11. Generic Drug Companies Image Figure 12. Improved New Drug Companies Image Figure 13. Global Pharmaceutical Formulation Development Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 15. Global Pharmaceutical Formulation Development Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pharmaceutical Formulation Development Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pharmaceutical Formulation Development Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmaceutical Formulation Development Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Formulation Development Service Revenue Market Share by Type (2021-2032) Figure 22. Global Pharmaceutical Formulation Development Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical Formulation Development Service Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Formulation Development Service Market Share by Type (2021-2032) Figure 26. North America Pharmaceutical Formulation Development Service Market Share by Application (2021-2032) Figure 27. North America Pharmaceutical Formulation Development Service Market Share by Country (2021-2032) Figure 28. United States Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Formulation Development Service Market Share by Type (2021-2032) Figure 33. Europe Pharmaceutical Formulation Development Service Market Share by Application (2021-2032) Figure 34. Europe Pharmaceutical Formulation Development Service Market Share by Country (2021-2032) Figure 35. Germany Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 36. France Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical Formulation Development Service Market Share by Type (2021-2032) Figure 43. China Pharmaceutical Formulation Development Service Market Share by Application (2021-2032) Figure 44. Asia Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pharmaceutical Formulation Development Service Market Share by Type (2021-2032) Figure 46. Asia Pharmaceutical Formulation Development Service Market Share by Application (2021-2032) Figure 47. Asia Pharmaceutical Formulation Development Service Market Share by Country (2021-2032) Figure 48. Japan Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 52. India Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pharmaceutical Formulation Development Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Poorly Soluble Drug Development Service
  • Highly Permeable Drug Development Service
  • Peptide/Protein Drug Development Service
  • High-Dose Drug Development Service
Applications
  • Innovative Drug R&D Companies
  • Generic Drug Companies
  • Improved New Drug Companies
Companies covered
  • Adragos Pharma
  • Agno Pharma
  • Ascendia Pharmaceutical Solutions
  • Aurigene Pharmaceutical Services
  • Avivia
  • CMC Pharmaceuticals
  • Coriolis Pharma
  • Crystal Pharmatech
  • Eoltinplas Pharmaceutical Company
  • Intertek
  • LGM Pharma
  • Lonza
  • Lucideon
  • Scantox
  • Suven Pharma
  • Seda
  • Sharp Services
  • Kemwell Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Poorly Soluble Drug Development Service
  5. 1.2.3 Highly Permeable Drug Development Service
  6. 1.2.4 Peptide/Protein Drug Development Service
  7. 1.2.5 High-Dose Drug Development Service
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Innovative Drug R&D Companies
  11. 1.3.3 Generic Drug Companies
  12. 1.3.4 Improved New Drug Companies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pharmaceutical Formulation Development Service Growth Trends by Region
  15. 1.5.1 Global Pharmaceutical Formulation Development Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pharmaceutical Formulation Development Service Market Size by Region (2021-2026)
  17. 1.5.3 Pharmaceutical Formulation Development Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pharmaceutical Formulation Development Service Market Dynamics
  1. 2.1 Pharmaceutical Formulation Development Service Industry Trends
  2. 2.2 Pharmaceutical Formulation Development Service Industry Drivers
  3. 2.3 Pharmaceutical Formulation Development Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Formulation Development Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical Formulation Development Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical Formulation Development Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical Formulation Development Service Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical Formulation Development Service Company, Product Type & Application
  5. 3.5 Global Pharmaceutical Formulation Development Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical Formulation Development Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical Formulation Development Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical Formulation Development Service Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Formulation Development Service Market by Type
  1. 4.1 Global Pharmaceutical Formulation Development Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical Formulation Development Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical Formulation Development Service Market Size Share by Type (2021-2032)
5 Pharmaceutical Formulation Development Service Market by Application
  1. 5.1 Global Pharmaceutical Formulation Development Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Formulation Development Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical Formulation Development Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Adragos Pharma
  2. 6.1.1 Adragos Pharma Company Information
  3. 6.1.2 Adragos Pharma Business Overview
  4. 6.1.3 Adragos Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Adragos Pharma Pharmaceutical Formulation Development Service Product Portfolio
  6. 6.1.5 Adragos Pharma Recent Developments
  7. 6.2 Agno Pharma
  8. 6.2.1 Agno Pharma Company Information
  9. 6.2.2 Agno Pharma Business Overview
  10. 6.2.3 Agno Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Agno Pharma Pharmaceutical Formulation Development Service Product Portfolio
  12. 6.2.5 Agno Pharma Recent Developments
  13. 6.3 Ascendia Pharmaceutical Solutions
  14. 6.3.1 Ascendia Pharmaceutical Solutions Company Information
  15. 6.3.2 Ascendia Pharmaceutical Solutions Business Overview
  16. 6.3.3 Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Product Portfolio
  18. 6.3.5 Ascendia Pharmaceutical Solutions Recent Developments
  19. 6.4 Aurigene Pharmaceutical Services
  20. 6.4.1 Aurigene Pharmaceutical Services Company Information
  21. 6.4.2 Aurigene Pharmaceutical Services Business Overview
  22. 6.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Product Portfolio
  24. 6.4.5 Aurigene Pharmaceutical Services Recent Developments
  25. 6.5 Avivia
  26. 6.5.1 Avivia Company Information
  27. 6.5.2 Avivia Business Overview
  28. 6.5.3 Avivia Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Avivia Pharmaceutical Formulation Development Service Product Portfolio
  30. 6.5.5 Avivia Recent Developments
  31. 6.6 CMC Pharmaceuticals
  32. 6.6.1 CMC Pharmaceuticals Company Information
  33. 6.6.2 CMC Pharmaceuticals Business Overview
  34. 6.6.3 CMC Pharmaceuticals Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CMC Pharmaceuticals Pharmaceutical Formulation Development Service Product Portfolio
  36. 6.6.5 CMC Pharmaceuticals Recent Developments
  37. 6.7 Coriolis Pharma
  38. 6.7.1 Coriolis Pharma Company Information
  39. 6.7.2 Coriolis Pharma Business Overview
  40. 6.7.3 Coriolis Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Coriolis Pharma Pharmaceutical Formulation Development Service Product Portfolio
  42. 6.7.5 Coriolis Pharma Recent Developments
  43. 6.8 Crystal Pharmatech
  44. 6.8.1 Crystal Pharmatech Company Information
  45. 6.8.2 Crystal Pharmatech Business Overview
  46. 6.8.3 Crystal Pharmatech Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Crystal Pharmatech Pharmaceutical Formulation Development Service Product Portfolio
  48. 6.8.5 Crystal Pharmatech Recent Developments
  49. 6.9 Eoltinplas Pharmaceutical Company
  50. 6.9.1 Eoltinplas Pharmaceutical Company Company Information
  51. 6.9.2 Eoltinplas Pharmaceutical Company Business Overview
  52. 6.9.3 Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Product Portfolio
  54. 6.9.5 Eoltinplas Pharmaceutical Company Recent Developments
  55. 6.10 Intertek
  56. 6.10.1 Intertek Company Information
  57. 6.10.2 Intertek Business Overview
  58. 6.10.3 Intertek Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Intertek Pharmaceutical Formulation Development Service Product Portfolio
  60. 6.10.5 Intertek Recent Developments
  61. 6.11 LGM Pharma
  62. 6.11.1 LGM Pharma Company Information
  63. 6.11.2 LGM Pharma Business Overview
  64. 6.11.3 LGM Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 LGM Pharma Pharmaceutical Formulation Development Service Product Portfolio
  66. 6.11.5 LGM Pharma Recent Developments
  67. 6.12 Lonza
  68. 6.12.1 Lonza Company Information
  69. 6.12.2 Lonza Business Overview
  70. 6.12.3 Lonza Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Lonza Pharmaceutical Formulation Development Service Product Portfolio
  72. 6.12.5 Lonza Recent Developments
  73. 6.13 Lucideon
  74. 6.13.1 Lucideon Company Information
  75. 6.13.2 Lucideon Business Overview
  76. 6.13.3 Lucideon Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Lucideon Pharmaceutical Formulation Development Service Product Portfolio
  78. 6.13.5 Lucideon Recent Developments
  79. 6.14 Scantox
  80. 6.14.1 Scantox Company Information
  81. 6.14.2 Scantox Business Overview
  82. 6.14.3 Scantox Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Scantox Pharmaceutical Formulation Development Service Product Portfolio
  84. 6.14.5 Scantox Recent Developments
  85. 6.15 Suven Pharma
  86. 6.15.1 Suven Pharma Company Information
  87. 6.15.2 Suven Pharma Business Overview
  88. 6.15.3 Suven Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Suven Pharma Pharmaceutical Formulation Development Service Product Portfolio
  90. 6.15.5 Suven Pharma Recent Developments
  91. 6.16 Seda
  92. 6.16.1 Seda Company Information
  93. 6.16.2 Seda Business Overview
  94. 6.16.3 Seda Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Seda Pharmaceutical Formulation Development Service Product Portfolio
  96. 6.16.5 Seda Recent Developments
  97. 6.17 Sharp Services
  98. 6.17.1 Sharp Services Company Information
  99. 6.17.2 Sharp Services Business Overview
  100. 6.17.3 Sharp Services Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sharp Services Pharmaceutical Formulation Development Service Product Portfolio
  102. 6.17.5 Sharp Services Recent Developments
  103. 6.18 Kemwell Pharma
  104. 6.18.1 Kemwell Pharma Company Information
  105. 6.18.2 Kemwell Pharma Business Overview
  106. 6.18.3 Kemwell Pharma Pharmaceutical Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Kemwell Pharma Pharmaceutical Formulation Development Service Product Portfolio
  108. 6.18.5 Kemwell Pharma Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Formulation Development Service Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Formulation Development Service Market Size by Type
  3. 7.2.1 North America Pharmaceutical Formulation Development Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical Formulation Development Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical Formulation Development Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical Formulation Development Service Market Size by Application
  7. 7.3.1 North America Pharmaceutical Formulation Development Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical Formulation Development Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical Formulation Development Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical Formulation Development Service Market Size by Country
  11. 7.4.1 North America Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical Formulation Development Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical Formulation Development Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical Formulation Development Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Formulation Development Service Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Formulation Development Service Market Size by Type
  3. 8.2.1 Europe Pharmaceutical Formulation Development Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical Formulation Development Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical Formulation Development Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical Formulation Development Service Market Size by Application
  7. 8.3.1 Europe Pharmaceutical Formulation Development Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical Formulation Development Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical Formulation Development Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical Formulation Development Service Market Size by Country
  11. 8.4.1 Europe Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical Formulation Development Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical Formulation Development Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical Formulation Development Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical Formulation Development Service Market Size (2021-2032)
  2. 9.2 China Pharmaceutical Formulation Development Service Market Size by Type
  3. 9.2.1 China Pharmaceutical Formulation Development Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical Formulation Development Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical Formulation Development Service Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical Formulation Development Service Market Size by Application
  7. 9.3.1 China Pharmaceutical Formulation Development Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical Formulation Development Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical Formulation Development Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical Formulation Development Service Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical Formulation Development Service Market Size by Type
  3. 10.2.1 Asia Pharmaceutical Formulation Development Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical Formulation Development Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical Formulation Development Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical Formulation Development Service Market Size by Application
  7. 10.3.1 Asia Pharmaceutical Formulation Development Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical Formulation Development Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical Formulation Development Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical Formulation Development Service Market Size by Country
  11. 10.4.1 Asia Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical Formulation Development Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical Formulation Development Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical Formulation Development Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst